China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-3.56	-3.08	-3.97	-3.4	-2.87	-20.7
Depreciation & Amortization	2.81	2.75	2.7	3.09	2.68	2.93
Share-Based Compensation	0	0	0.08	0.02	0	0
Other Operating Activities	0.93	-0.37	0.78	0.05	0.15	18.38
Operating Cash Flow	0.18	-0.7	-0.41	-0.25	-0.04	0.61
Operating Cash Flow Growth	-	-	-	-	-	-67.68%
Capital Expenditures	-0.07	-0.01	-0.4	-0.44	-0.87	-0.14
Investing Cash Flow	-0.07	-0.01	-0.4	-0.44	-0.87	-0.14
Debt Issued / Paid	-0.44	0.07	-1.77	4.6	0.62	-1.73
Financing Cash Flow	-0.44	0.07	-1.77	4.6	0.62	-1.73
Exchange Rate Effect	-0.01	0.03	-0.25	-0.01	0.06	-0.02
Net Cash Flow	-0.33	-0.61	-2.83	3.9	-0.23	-1.28
Free Cash Flow	0.12	-0.71	-0.81	-0.69	-0.91	0.47
Free Cash Flow Growth	-	-	-	-	-	-74.20%
Free Cash Flow Margin	1.80%	-10.14%	-10.01%	-7.13%	-8.37%	4.32%
Free Cash Flow Per Share	0.01	-0.21	-0.77	-0.75	-1.04	0.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).